Drug class · Oncology & immunology

TNF blockers

Biologics that block tumor necrosis factor, including adalimumab, infliximab, etanercept and their biosimilars.

63 finished products listed with the FDA

FDA-listed products

Finished products in the TNF blockers class, A–Z by brand
ProductStrengthForm · routeLabelerProduct NDC
Cimziacertolizumab pegolCertolizumab pegol 200 mg/mLInjection, SolutionSubcutaneousUCB, Inc.50474-710
Cimziacertolizumab pegolCertolizumab pegol 200 mg/mLInjection, SolutionSubcutaneousUCB, Inc.50474-750
EnbreletanerceptEtanercept 50 mg/mLSolutionSubcutaneousImmunex Corporation58406-021
EnbreletanerceptEtanercept 25 mg/.5mLSolutionSubcutaneousImmunex Corporation58406-010
EnbreletanerceptEtanercept 50 mg/mLSolutionSubcutaneousImmunex Corporation58406-032
EnbreletanerceptEtanercept 50 mg/mLSolutionSubcutaneousImmunex Corporation58406-044
EnbreletanerceptEtanercept 25 mg/.5mLSolutionSubcutaneousImmunex Corporation58406-055
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousA-S Medication Solutions50090-6705
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousA-S Medication Solutions50090-6706
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousA-S Medication Solutions50090-6707
Hyrimozadalimumab-adazAdalimumab 10 mg/.1mLInjection, SolutionSubcutaneousSandoz Inc61314-509
Hyrimozadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousSandoz Inc61314-454
Hyrimozadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousSandoz Inc61314-473
Hyrimozadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousSandoz Inc61314-476
Hyrimozadalimumab-adazAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-102
Hyrimozadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousCordavis Limited83457-100
Hyrimozadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousCordavis Limited83457-101
Hyrimozadalimumab-adazAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-103
Hyrimozadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-107
Hyrimozadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousCordavis Limited83457-108
Hyrimozadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-113
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousOrganon LLC78206-185
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousOrganon LLC78206-183
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousOrganon LLC78206-184
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousOrganon LLC78206-186

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in